Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed Apr 7, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-04-05$25.59/sh−5,000$127,950→ 326,227 total(indirect: By Trust)
Holdings
- 16,629
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.